Athersys hires pharma, biotech leader as next CEO

Athersys hires pharma, biotech leader as next CEO
·2 min read

Athersys Inc., the adult stem cell company in Cleveland, has hired a senior pharmaceutical and biotech executive as its next CEO to complete the company's efforts to commercialize its MultiStem therapy. Daniel Camardo is executive vice president, head of the rare disease and inflammation business units, and U.S. president at Horizon Therapeutics, the Irish biotech company. Camardo also will join the Athersys board.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting